Gliclazide and Cholangitis - a phase IV clinical study of FDA data

Summary:

Cholangitis is reported as a side effect among people who take Gliclazide (gliclazide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Metformin, and have Pancreatic carcinoma metastatic.

The phase IV clinical study analyzes which people have Cholangitis when taking Gliclazide. It is created by eHealthMe based on reports of 27,903 people who have side effects when taking Gliclazide from the FDA, and is updated regularly.

What is Gliclazide?

Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.

What is Cholangitis?

Cholangitis (infection of the bile duct) is found to be associated with 650 drugs and 752 conditions by eHealthMe. Check the latest studies of Cholangitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

27,903 people reported to have side effects when taking Gliclazide.
Among them, 15 people (0.05%) have Cholangitis.

Among these 15 people:

How long have people been on Gliclazide when they have Cholangitis? *

What is the gender of people who have Cholangitis when taking Gliclazide? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Cholangitis when taking Gliclazide? *

What are other drugs people take besides Gliclazide? *

What are other side effects people have besides Cholangitis? *

Fever: 3 people, 20.00%
Gallstones (stone formation by bile component): 2 people, 13.33%
Pancreatitis (inflammation of pancreas): 2 people, 13.33%
Bile Duct Obstruction (blockage in the tubes that carry bile from the liver to the gallbladder): 2 people, 13.33%
Choledocholithiasis (stones in the common bile duct): 2 people, 13.33%
Liver Function Tests Nos Abnormal: 2 people, 13.33%
Abdominal Pain: 2 people, 13.33%
Pancreatic Carcinoma Stage Iii (pancreatic cancer stage iii): 1 person, 6.67%
Electrolyte Imbalance: 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 2 people, 13.33%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 13.33%
Wax Blockage: 1 person, 6.67%
Dyspnea (difficult or laboured breathing): 1 person, 6.67%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 1 person, 6.67%
Anaemia (lack of blood): 1 person, 6.67%
Ankylosing Spondylitis (type of arthritis affecting the spine): 1 person, 6.67%
Cancer Pain: 1 person, 6.67%
Carcinoid Tumor: 1 person, 6.67%
Cold Type Haemolytic Anaemia (anaemia of abnormal breakdown of red blood cells): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Gliclazide and have Cholangitis?

- Check whether Cholangitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gliclazide:

Gliclazide (28,131 reports)

Cholangitis treatments and more:

Cholangitis (7,720 reports)

Browse all side effects of Gliclazide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cholangitis:

Cholangitis (650 drugs)

Browse all the conditions that are associated with Cholangitis:

Cholangitis (752 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gliclazide (the active ingredients of Gliclazide) and Gliclazide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.